Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX was delisted on the 23rd of January, 2024.
81 hedge funds and large institutions have $392M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 11 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 18
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
9% more funds holding
Funds holding: 74 → 81 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
19% less capital invested
Capital invested by funds: $485M → $392M (-$92.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$12.1M |
| 2 |
ROTUOC
Regents of the University of California
Oakland,
California
|
+$7.8M |
| 3 |
CC
Casdin Capital
New York
|
+$6.18M |
| 4 |
Morgan Stanley
New York
|
+$5.58M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$14.7M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$9.6M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$9.19M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$5.48M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.76M |
ORTX Hedge Fund Activity: Q2 2020 in Review
81 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q2 2020, worth a combined $392M — down 19% from $485M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ORTX positions and 11 closed out — a net gain of 7 holders — while 30 added to existing stakes and 18 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $12.1M. The largest seller was Deerfield Management, cutting an estimated $14.7M.
- 81 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q2 2020, up from 74 in Q1 2020.
- Funds reported $392M of Orchard Therapeutics plc American Depositary Shares stock for Q2 2020, down 19% quarter-over-quarter.
- 18 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q2 2020 and 11 closed out, a net change of +7 holders.
- The largest Orchard Therapeutics plc American Depositary Shares buyer in Q2 2020 was JP Morgan Chase, an estimated $12.1M added.
- The largest Orchard Therapeutics plc American Depositary Shares seller in Q2 2020 was Deerfield Management, an estimated $14.7M sold.
Based on aggregated 13F filings for Q2 2020.